Showing results (521-530 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|May 30, 2025
Income-Based Disparities in Opioid Prescription Dispensing Among Public Drug Plan Beneficiaries in Canada from 2010 to 2018: A Population-Based and Sex-Stratified Retrospective StudyMhd Wasem Alsabbagh, Moad Alsefaou, Susan J Elliott, et al.
Drugs - Real World Outcomes|February 21, 2024
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry StudyHürrem Gül Öngen, Bahri Akdeniz, Mehmet Akif Düzenli, et al.
Drugs - Real World Outcomes|February 18, 2024
Disease-Modifying Medications in Patients with Rheumatoid Arthritis in the USA: Trends from 2016 to 2021Samuel K Peasah, Elizabeth C S Swart, Yan Huang, et al.
Drugs - Real World Outcomes|March 19, 2024
Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database AnalysisWinghan Jacqueline Kwong, Kevin Wang, Peng Wang, et al.
Drugs - Real World Outcomes|July 2, 2024
Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's DiseaseRuggero Bacchin, Marco Liccari, Mauro Catalan, et al.
Drugs - Real World Outcomes|July 2, 2024
PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBaseDahyun Park, Sungho Bea, Ji-Hwan Bae, et al.
Drugs - Real World Outcomes|April 10, 2024
Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort StudyMasahiko Miyashiro, Teita Asano, Yutaka Ishii, et al.
Drugs - Real World Outcomes|February 6, 2024
Causality Assessment Between Drugs and Fatal Cerebral Haemorrhage Using Electronic Medical Records: Comparative Evaluation of Disease-Specific and Conventional MethodsMiki Ohta, Satoru Miyawaki, Shinichiroh Yokota, et al.
Drugs - Real World Outcomes|August 28, 2024
Prognostic Factors in Japanese EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Real-World Single-Center Retrospective Cohort StudyKenta Takashima, Hiroki Wakabayashi, Yu Murakami, et al.
Drugs - Real World Outcomes|September 7, 2024
Prescription Patterns of Inducers and Inhibitors of Cytochrome P450 and Their Potential Drug Interactions in the Real World: A Cross-Sectional StudyLuis Fernando Valladales-Restrepo, Juan Alberto Ospina-Cano, Brayan Stiven Aristizábal-Carmona, et al.
Pageof 55